This site provides general eye-health education. It cannot replace individual assessment by a registered doctor, and does not offer personal diagnosis, prescriptions, bookings, sales or referrals.

If translations differ or are incomplete, the Traditional Chinese (zh-Hant) text on this site prevails.

Cornea and ocular surface · AS

Keratoconus: progression, acute hydrops, and care concepts

Progression monitoring · acute hydrops · optics / CXL classes

Last reviewed: 2026-09-07 · 潘家健醫生

Key points

  • Keratoconus is corneal thinning and protrusion; progression monitoring and optics/CXL are specialist class discussions — no brand ranking.
  • Acute hydrops: sudden vision drop, markedly white cloudy cornea, severe pain or photophobia — emergency path.
  • Contact-lens-related severe red pain with discharge: do not delay after lens removal — exclude infectious keratitis.
  • Other progression or optical problems: same-day specialist assessment when possible.

What it is

Keratoconus is a corneal ectatic disease: the central or paracentral cornea gradually thins and bulges forward in a cone shape, causing irregular astigmatism and deepening myopia. Vision blurs and spectacles often cannot fully correct it.

Public-education points:

  • Often found from adolescence to young adulthood; both eyes may be involved, but asymmetry is common.
  • Causes are multifactorial: genetic tendency, environment and behaviour (especially forceful eye rubbing and severe allergic eye disease).
  • Progression means ongoing steepening, thinning, or clear worsening of vision / refraction — whether it is “still progressing” needs serial topography / tomography comparison, not feeling alone.
  • Acute corneal hydrops: sudden break in Descemet’s membrane (and related structure), aqueous entering the stroma, rapid corneal clouding, sudden vision drop, irritation and pain — a known but relatively uncommon acute complication.
  • Two care layers (concepts): (1) slow or stop biomechanical worsening — corneal collagen cross-linking (CXL) class; (2) improve optical quality — spectacles, rigid gas-permeable lenses, scleral lenses and similar classes; transplantation is considered later.

This page discusses classes and principles only — no brand comparison and no success rates. See related pages for refractive-surgery screening, allergy and rubbing, and contact-lens infection red flags.

Common symptoms

  • Gradual blur; astigmatism / myopia increasing clearly over a short period
  • Many pairs of glasses still unsatisfactory; ghosting, glare, poor night vision; one eye clearly worse
  • Young people who itch and rub often from allergy need particular attention
  • In acute hydrops: sudden worse blur in one eye, white cloudy cornea, light sensitivity, tearing, discomfort
  • Early disease can resemble “ordinary myopia and astigmatism”, so topography / tomography matters in screening (including before refractive surgery)

Go to A&E now (if you cannot get there: call 999)

  • Suspected acute hydrops: sudden vision drop, clearly cloudy/white cornea, severe pain or marked light sensitivity
  • Contact-lens-related severe red painful eye with heavy discharge — rule out infectious keratitis; do not delay if pain continues after lens removal

Same-day / prompt ophthalmology when possible

  • Large refraction change over a short time, or spectacles cannot bring one eye to a reasonable acuity — see an ophthalmologist as soon as possible
  • Known keratoconus with new pain or sudden worse blur
  • Newly diagnosed children / teens who need assessment of whether progression continues

Routine clinic follow-up

  • After diagnosis: repeat topography / tomography, refraction and contact-lens review on the schedule your doctor sets
  • Discussion of whether CXL assessment criteria are met (usually emphasises documented progression)
  • Allergy control and stop-rubbing education, plus prescription medicines when needed

Tests, optics and CXL (classes)

  • Tests: vision, refraction, slit lamp; corneal topography / tomography; thickness. Individual — not a guaranteed checklist
  • Optics: spectacles / soft lenses; RGP improves optics and does not by itself stop progression; scleral / mini-scleral; hybrid / piggyback classes — no brand names
  • CXL: riboflavin plus UVA aiming to strengthen biomechanics and slow or halt progression; epi-off has more public evidence; important to consider when progression is documented
  • Oral riboflavin does not replace a clinical CXL procedure; CXL does not guarantee return to “normal” vision
  • Late or severe scarring / extreme thinning: a specialist may discuss corneal transplant classes — individual judgement, no success-rate comparison

Common myths

MythCloser to the evidence
“Keratoconus is only a laser-surgery complication”Keratoconus can exist on its own; pre-op screening is meant to find high-risk or unsuitable corneas.
“Hard lenses stop the disease”RGP mainly improves optics; it does not replace progression monitoring and CXL assessment.
“CXL means vision will be normal”CXL is mainly about biomechanical stability and slowing progression — not a vision guarantee.
“Rubbing a bit is fine”Forceful rubbing is linked with progression; treat allergy itch medically rather than as a habit.
“Hydrops always means immediate transplant”Hydrops is usually managed first; transplant timing is a specialty decision.
“Children never get keratoconus”Young people also need vigilance; after a new diagnosis, progression is often reassessed.
Public education only; not a consultation, booking or brand page; no cure or guarantee claims; no device or lens trade names; does not replace a face-to-face visit.

Selected public references (not a full bibliography)

These are the public studies this page draws on. PMID links go to PubMed (US National Library of Medicine) so you can check them. Figures are from those studies — not your prognosis and not a clinic success rate. Links are not a shop.

  1. Gomes JAP, Tan D, Rapuano CJ, et al. Global Consensus on Keratoconus and Ectatic Diseases. Cornea. 2015;34(4):359-369. PMID 25738235圓錐角膜/擴張性疾病全球共識。定義、進展與管理原則屬教育層次;其後亦有第二輪共識材料(Gomes/Hafezi/Ambrósio 等),本站不另造條目。
  2. Deshmukh R, et al. Management of keratoconus: an updated review. Front Med (Lausanne). 2023;10:1212314. DOI 10.3389/fmed.2023.1212314. 圓錐角膜處理更新綜述。光學矯正與交聯為類別討論;不比較品牌或報成功率。
  3. Wollensak G, Spoerl E, Seiler T Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620-627. PMID 12719068核黃素+UVA 角膜膠原交聯早期臨床報告。目標為強化生物力學、減慢進展;不保證視力回復。
  4. Wittig-Silva C, Chan E, Islam FM, et al. A randomized, controlled trial of corneal collagen cross-linking in progressive keratoconus: three-year results. Ophthalmology. 2014;121(4):812-821. PMID 24393351進展性圓錐角膜交聯隨機對照三年結果。epi-off 證據較多的公開依據之一;個別是否適合須醫生評估。

This is general medical information, not a diagnosis, and cannot replace an in-person consultation with a registered ophthalmologist, refraction, or a dilated fundus exam. It is not advice to use any medicine or undergo any procedure. Medicines (including off-label use), laser or surgery must be decided by a registered doctor after examination, according to indications and Hong Kong registration. Figures from the literature are published averages, not any clinic’s results. This site does not book, prescribe or refer. Do not change treatment on your own.